172 filings
Page 3 of 9
8-K
l9h7k8m2rxrwg lp3k
26 Apr 23
Unregistered Sales of Equity Securities
6:05pm
8-K
p3by2ktzdw7c9ga
24 Apr 23
Entry into a Material Definitive Agreement
8:08am
ARS
8p4 8br9sb5d5d3
17 Apr 23
Annual report to shareholders
5:27pm
DEFA14A
0k1gg wx2
17 Apr 23
Additional proxy soliciting materials
4:39pm
8-K
fchr8f8 ygls81fpxr7q
14 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:38pm
S-8
rgozu 66eh4
23 Mar 23
Registration of securities for employees
7:54am
8-K
zd5f9v 6xi8v86c78w
23 Mar 23
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
6:40am
8-K
gtb7n2n 1c2
24 Feb 23
Departure of Directors or Certain Officers
4:46pm
8-K
908g42p3d4xfhsiyn
4 Jan 23
Entry into a Material Definitive Agreement
5:01pm
8-K
86m7lvku ftf
18 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
w5o2b4zwc1hz4qyor6yj
9 Nov 22
Applied Therapeutics Reports Third Quarter 2022 Financial Results
7:08am
8-K
f5r8eq3qclfqes
28 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:15pm
DEFA14A
813nhli 3s
9 Sep 22
Additional proxy soliciting materials
4:18pm
PRE 14A
7gkn7u0dymwcid0smae2
26 Aug 22
Preliminary proxy
4:15pm
8-K
2xptsaqfz45rec8i
12 Aug 22
Applied Therapeutics Reports Second Quarter 2022 Financial Results
7:06am